Atlas FDA

RxSight Light Adjustable Lens and Light Delivery Device

FDA premarket approval P160055/S017 · decided 2021-03-10

Approval details

PMA number
P160055
Supplement
S017
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
RxSight Light Adjustable Lens and Light Delivery Device
Generic name
Light adjustable lens (LAL) and light delivery device (LDD)
Applicant
Rxsight, Inc.
Date received
2021-02-08
Decision date
2021-03-10
Days to decision
30 days
Decision code
APPR
Product code
PZK
Advisory committee
Ophthalmic
Expedited review
No
Location
Aliso Viejo, CA
Statement
Approval of the revised protocol for the post-approval study (PAS) protocol.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
RxSight® Insertion Device (K261174)Rxsight, Inc.2026-06-10
RxSight® Insertion Device (63002) (K231838)Rxsight, Inc.2023-08-15
RxSight Insertion Device (K231466)Rxsight, Inc.2023-06-12
RxSight Contact Lens (K201909)Rxsight, Inc.2020-09-10
RxSight Insertion Device (K192926)Rxsight, Inc.2020-01-17
RxSight Insertion Device (K181401)Rxsight, Inc.2018-07-26